2018
DOI: 10.1016/j.fertnstert.2018.02.068
|View full text |Cite
|
Sign up to set email alerts
|

ART outcomes in female to male transgender patients: a new frontier in reproductive medicine

Abstract: BACKGROUND: Surmounting evidence suggests that frozen embryo transfer results in higher pregnancy and live birth rates compared to fresh transfer during in vitro fertilization (IVF) (1, 2). There is conflicting data regarding neonatal outcomes: preterm birth, pre-eclampsia and birth weight (3, 4). The effect of embryo cryopreservation on the placental morphology is not well understood. OBJECTIVE: To evaluate differences in placental morphology from infants conceived with cryothaw compared to fresh transfer in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…Transgender men who have been undergoing testosterone therapy and who wish to obtain eggs for fertilization or freezing are generally stimulated with gonadotropins. This is usually done following a period of T cessation that is sufficient for the menstrual cycle to resume (Adeleye et al, 2019;Broughton and Omurtag, 2017;Leung et al, 2018). There is strong evidence that transgender men who have taken T can produce viable, developmentally competent eggs after discontinuing its use (Adeleye et al, 2019;Broughton and Omurtag, 2017;Leung et al, 2018;Light et al, 2014), but to date, there are no publications regarding the quality and developmental capacity of eggs retrieved from transgender men who remain on HT.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Transgender men who have been undergoing testosterone therapy and who wish to obtain eggs for fertilization or freezing are generally stimulated with gonadotropins. This is usually done following a period of T cessation that is sufficient for the menstrual cycle to resume (Adeleye et al, 2019;Broughton and Omurtag, 2017;Leung et al, 2018). There is strong evidence that transgender men who have taken T can produce viable, developmentally competent eggs after discontinuing its use (Adeleye et al, 2019;Broughton and Omurtag, 2017;Leung et al, 2018;Light et al, 2014), but to date, there are no publications regarding the quality and developmental capacity of eggs retrieved from transgender men who remain on HT.…”
Section: Discussionmentioning
confidence: 99%
“…However, the ovarian tissue follicular pool is not diminished (De Roo et al, 2016;Van Den Broecke et al, 2001) (Light et al, 2014). Case reports have been published of subjects successfully undergoing IVF after temporarily discontinuing testosterone therapy for 1-12 months, and healthy live births were reported (Adeleye et al, 2019;Broughton and Omurtag, 2017;Leung et al, 2018). These data suggest that the follicular pool and oocyte quality are preserved.…”
Section: Introductionmentioning
confidence: 93%
See 1 more Smart Citation
“…Accordingly, if a transgender male 73 presents for fertility treatment now or in the near future and plans to have the pregnancy carried 74 by a cis-female partner or gestational carrier, the best option is in vitro fertilization (IVF) after 75 ovarian stimulation and oocyte retrieval. Due to the unknown effects of high-level testosterone 76 on ovarian response and oocyte quality, the current recommended practice before IVF is 77 discontinuation of testosterone to allow the resumption of menses (Adeleye et al, 2019;78 Broughton and Omurtag, 2017; Leung et al, 2018). While this treatment regimen can be 79 effective, HT cessation for the purpose of fertility treatment has been reported to cause 80 significant psychological distress in the form of gender dysphoria attributed to the gender-81 incongruous effects of testosterone withdrawal, estrogen exposure, and menses (Armuand et 82 al., 2017).…”
Section: Introduction 41mentioning
confidence: 99%
“…The difference in 366 E2 levels after eCG was surprising because a similar number of oocytes were collected after 367 stimulation. In human IVF cycles, the peak E2 level achieved directly correlates with the 368 number of oocytes collected at the time of retrieval (Chenette et al, 1990), and during reported 369 IVF cycles in transgender males, the peak E2 levels, as well as the number of oocytes 370 collected, have been reported to be similar to female controls, although higher doses of 371 gonadotropins were used for transgender males (Leung et al, 2018). Lower E2 levels here may 372 reflect the lower number of CLs in the T group.…”
mentioning
confidence: 99%